VTRS FY 2023 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$17B

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$15.4B-5.1% YoY

Gross Profit

$6.4B41.7% margin

Operating Income

$766M5.0% margin

Net Income

$55M0.4% margin

EPS (Diluted)

$0.05

Cash Flow

Operating Cash Flow

$2.8B

Free Cash Flow

$2.3B

Stock-Based Comp.

$181M

Balance Sheet

Total Assets

$47.7B

Total Liabilities

$27.2B

Stockholders' Equity

$20.5B

Cash & Equivalents

$992M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15.4B	$16.3B	-5.1%
Gross Profit	$6.4B	$6.5B	-0.9%
Operating Income	$766M	$1.6B	-52.6%
Net Income	$55M	$2.1B	-97.4%